THE DEAL, AT A GLANCE
From the announcementBlue Arbor
01What it doesBlue Arbor builds implantable neuromuscular interfaces that detect voluntary nerve and muscle signals and translate them into naturalistic, multidegree-of-freedom…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by chief executive officer Noel Borton, DealroomFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedBlue Arbor raised $10.2M Seed, announced 2026-08-25From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersBlue Arbor's $10.2M Seed round is a below-median FinTech funding event, positioned at the 30th percentile by round size within a sector that recorded 512 other funding…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Blue Arbor · Financing Record
Explore source-linked visual explanations for Blue Arbor. Unsupported claims are withheld while source review continues.
Record 11229 · Recorded date: 2026-08-25
Explore company records →